GGrantIndex
Sort

51,593 grants matching hepatitis

IGF::OT::IGF ANTI FUSOBACTERIUM NUCLEATUM VACCINE FOR COLORECTAL CANCER IMMUNOPREVENTION

$423,381
Steven Monroe Lipkin · Weill Medical Coll Of Cornell Univ · N01 · FY2016 · CA

HEPATIC METABOLISM OF DIET DERIVED LIPOPROTIENS

$423,330
Palo Alto Medical Foundation Res Inst · R01 · FY2000 · DK

Core 001 - Virology Core

$423,271
Mansun Law · Scripps Research Institute, The · P01 · FY2025 · AI

Core-002 - Non-Human Primate Core

$423,271
Christopher Yeh Chen · Scripps Research Institute, The · P01 · FY2024 · AI

Core-002 - Non-Human Primate Core

$423,271
Christopher Yeh Chen · Scripps Research Institute, The · P01 · FY2023 · AI

Computational discovery of effective hepatitis C intervention strategies

$423,260
Harel Dahari · Loyola University Chicago · R01 · FY2017 · GM

International HIV ARV Adherence, Resistance and Survival

$423,201
David Roy Bangsberg · University Of California, San Francisco · R01 · FY2008 · MH

Illuminating Galectin-3 Interactions to Disrupt Hepatic Fibrosis

$423,185
Mia L Huang · Scripps Research Institute, The · R56 · FY2021 · DK

Molecular Basis of Circadian Desynchrony in Cardiometabolic Disease

$423,149
Joseph T Bass · Northwestern University At Chicago · R01 · FY2010 · HL

HAART optimism, drug use and risky sexual behavior among MSM in British Columbia.

$423,107
Robert S Hogg · Simon Fraser University · R01 · FY2012 · DA

Hepatic degradation of cytochrome P450 enzymes

$423,094
Maria Almira Correia · University Of California, San Francisco · R01 · FY2012 · GM

The musculoskeletal cost of metastatic colorectal cancer

$423,084
Joshua Huot · Indiana University Indianapolis · R37 · FY2025 · CA

MECHANISMS AND STRATEGIES FOR INSULIN RESISTANCE IN AIDS

$423,072
Massachusetts General Hospital · R01 · FY2004 · DK

MECHANISMS AND STRATEGIES FOR INSULIN RESISTANCE IN AIDS

$423,072
Massachusetts General Hospital · R01 · FY2003 · DK

Core D: Clinical Sciences

$423,040
Jeffrey M Jacobson · Case Western Reserve University · P30 · FY2025 · AI

Viral and Cellular Determinants of Hepatitis B Virus Pathogenesis

$423,021
Robert Schneider · New York University School Of Medicine · R01 · FY2008 · CA

In vivo probes for the APJ receptor.

$423,010
Rangan Maitra · Research Triangle Institute · R01 · FY2015 · HD

Role of TLR7 in progression and treatment of alcoholic hepatitis

$423,003
Ekihiro Seki · Cedars-Sinai Medical Center · R01 · FY2021 · AA

Role of TLR7 in progression and treatment of alcoholic hepatitis

$423,003
Ekihiro Seki · Cedars-Sinai Medical Center · R01 · FY2019 · AA

Role of TLR7 in progression and treatment of alcoholic hepatitis

$423,003
Ekihiro Seki · Cedars-Sinai Medical Center · R01 · FY2020 · AA

Role of TLR7 in progression and treatment of alcoholic hepatitis

$423,003
Ekihiro Seki · Cedars-Sinai Medical Center · R01 · FY2022 · AA

Manipulation of Type I Interferon by HIV Infection

$423,000
David Jesse Sanchez · Western University Of Health Sciences · R15 · FY2018 · AI

Lipase Maturation Factor 1 in Hypertriglyceridemia

$423,000
Miklos Peterfy · Western University Of Health Sciences · R15 · FY2021 · HL

Hepatocellular Carcinoma in Antitrypsin Deficiency

$422,959
David H Perlmutter · University Of Pittsburgh At Pittsburgh · R01 · FY2009 · DK

Regulation of chronic viral infection by co-inhibitory pathways

$422,938
Arlene H Sharpe · Harvard Medical School · R56 · FY2009 · AI